<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Iranian Journal of Public Health">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>Int J Cancer Manag</JournalTitle>
            <Issn>2538-497X</Issn>
            <Volume>11</Volume>
            <Issue>9</Issue>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>9</Month>
                <Day>30</Day>
            </PubDate>
            <journal_id_doi>10.5812/ijcm.69595</journal_id_doi>
        </Journal>
        <title locale="en_US">Recurrent Hodgkin’s Lymphoma with Bleeding: A Case Report</title>
        <AuthorList>
            <Author>
                <FirstName>Nematollah</FirstName>
                <LastName>Rostami</LastName>
                <affiliation locale="en_US">Department of Hematology and Oncology, Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran,Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Zohreh</FirstName>
                <LastName>Maghsoomi</LastName>
                <affiliation locale="en_US">Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran, Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, P.O. Box: 0938890301, Tehran, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Farzad</FirstName>
                <LastName>Dashti</LastName>
                <affiliation locale="en_US">Department of Internal Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, , Tehran,Iran</affiliation>
            </Author>
        </AuthorList>
        <ArticleType>Case Report</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>8</Month>
                <Day>9</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2018</Year>
                <Month>4</Month>
                <Day>19</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2018</Year>
                <Month>9</Month>
                <Day>30</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2018</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Introduction : One of the rare platelet dysfunction, which is impairment of receptor GPIIb/IIIa and platelet aggregation defect, is acquired Glanzmann’s thrombasthenia. A common cause of this thrombasthenia is an autoantibody or plasma protein inhibitor against a normal GPIIb/IIIa glycoprotein. Case Presentation : In this case report, a 28-year-old female with a history of treated Hodgkin’s lymphoma presented with a menometrorrhagia and ecchymosis. Before that, she had no bleeding history and there was no family history bleeding tendency. Laboratory findings revealed bleeding time &gt; 10 minutes, normal partial thromboplastin time (APTT), prothrombin time (PT), fibrinogen, and von Willebrand factor. Platelet-aggregation studies showed no aggregation to adenosine diphosphate (ADP), collagen, and a normal response to ristocetin. The clinical history, medical history, and laboratory findings supported a diagnosis of acquired Glanzmann’s thrombasthenia. Imaging revealed significant lymph nodes was compatible with recurrent disease. The patient’s menorrhagia and bleeding tendency were controlled by systemic chemotherapy. Conclusions : This report shows the association of acquired thrombasthenia with the recurrent Hodgkin’s lymphoma, which can be controlled by remission induction chemotherapy.</abstract>
        <web_url>http://intjcancermanag.com/en/articles/69595.html</web_url>
        <pdf_url>https://cdn.neoscriber.org/cdn/dl/dea6bf48-c0e0-11e8-95ff-3752f3e54f71</pdf_url>
    </Article>
</Articles>
